世界

薬剤溶出ステント(DES)の世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Drug Eluting Stents (DES) – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Drug Eluting Stents (DES) – Medical Devices Pipeline Assessment, 2016″ provides an overview of Drug Eluting Stents (DES) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Eluting Stents (DES) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Drug Eluting Stents (DES) under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Drug Eluting Stents (DES) and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Drug Eluting Stents (DES) under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

乾癬性関節炎治療の世界市場:医薬品予測・市場分析(~2025)

2017年3月6日 // 0 Comments

PharmaPoint: Psoriatic Arthritis – Global Drug Forecast and Market Analysis to 2025
Summary

Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially those of the lower extremities and distal joints of the fingers and toes as well as the back and sacroiliac joints of the pelvis. In approximately 80% of PsA patients, skin lesions of psoriasis (PsO), an immune-mediated skin disease, manifest prior to the development of PsA, typically by five to 10 years. PsA most commonly develops between the ages of 30 and 50 and affects men and women equally. Although, early diagnosis and intervention are key in preventing irreversible joint damage, many PsA patients are undiagnosed and go untreated for months or years.

GlobalData projects the PsA market in 7MM to experience strong growth during the forecast period at a CAGR of 10.74%. By the forecast’s end in 2025, sales will increase to over $12.58 billion from $4.53 billion in 2015. This growth will be driven primarily by the increase in diagnosed prevalent cases from 1,044,022 in 2015 to 1,520,471 in 2025. Further, the launch of the IL-17 inhibitors, including Novartis’ Cosentyx, Eli Lilly’s Taltz, and AstraZeneca’s Lumicef, as well as the launch of Celgene’s oral therapy Otezla, will expand the treatment armamentarium for PsA driving growth in the market.

Highlights

Key Questions Answered

– How large an impact will biosimilars have on the PsA market? What do dermatologists, rheumatologists, and key opinion leaders across the 7MM think about the evolving treatment landscape?
– What opportunities remain in the market for new product entrants?
– What are the most promising late-stage pipeline drugs and how will their launch shape the future treatment landscape in the PsA market?
– According to KOLs, what are the most important unmet needs in PsA? Will these needs be addressed by pipeline agents? What needs will remain by the end of the forecast period in 2025?
– What clinical and commercial factors are likely to affect uptake of PsA therapies in the US, 5EU, and Japan?

Key Findings

– The PsA market is currently very dynamic, with effective biologic therapies recently approved, including interleukin-17 (IL-17) inhibitors – Cosentyx, Taltz, and Lumicef – and oral phosphodiesterase-4 (PDE4) – Otezla.
– Novel biologic therapies will challenge the current anti-TNF biologics in an attempt to dislodge their stronghold, if their safety and efficacy profiles are proven once they enter the market.
– The impending patent cliff for biologics will allow for the emergence of biosimilars to all the marketed biologic brands. Patent expiries take place during the forecast period for the current market leaders such as Johnson & Johnson’s Remicade (infliximab), AbbVie’s Humira (adalimumab), Amgen’s Enbrel (etanercept) and Johnson & Johnson’s Stelara (ustekinumab).
– The drivers for market growth will include the increasing diagnosis rate as well as the recent approval of novel therapies. The main challenge for individual drugs will be to distinguish themselves in a crowded marketplace, comprising a highly diversified field of therapies, with existing drugs struggling to increase their patient share.

Scope

– Overview of PsA, including epidemiology, etiology, pathophysiology, symptoms and country-specific diagnosis and treatment recommendations.
– Annualized PsA market revenue, annual cost of therapy and treatment usage pattern data from 2015 and forecast for ten years to 2025.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs, and implications for the PsA market.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of novel products- including promising IL-17 inhibitors – and biosimilars – such as Celltrion’s Hospira, Sandoz’s Erelzi, Biogen/Samsung Bioepies’ Flixabi and Benepali, and Amgen’s Amjevita.
– Analysis of the current and future market competition in the global PsA market (7MM). Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global Psoriasis market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Psoriasis market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track drug sales in the global PsA market from 2015-2025.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

人工心臓(VAD)の世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Ventricular Assist Devices – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Ventricular Assist Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Ventricular Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ventricular Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Ventricular Assist Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Ventricular Assist Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Ventricular Assist Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

経皮吸収型ドラッグデリバリーの世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Transdermal Drug Delivery – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Transdermal Drug Delivery – Medical Devices Pipeline Assessment, 2016″ provides an overview of Transdermal Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Transdermal Drug Delivery under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Transdermal Drug Delivery under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

腎透析機器の世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Renal Dialysis Equipment – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Renal Dialysis Equipment – Medical Devices Pipeline Assessment, 2016″ provides an overview of Renal Dialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Renal Dialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Renal Dialysis Equipment under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Renal Dialysis Equipment and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Renal Dialysis Equipment under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

末梢血管用ステントの世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2016″ provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Peripheral Vascular Stents under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Peripheral Vascular Stents under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

脳深部刺激機器の世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Deep Brain Stimulators – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Deep Brain Stimulators – Medical Devices Pipeline Assessment, 2016″ provides an overview of Deep Brain Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Deep Brain Stimulators under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Deep Brain Stimulators under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

持続血糖測定(CGM)システムの世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Continuous Glucose Monitoring Systems – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Continuous Glucose Monitoring Systems – Medical Devices Pipeline Assessment, 2016″ provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Continuous Glucose Monitoring Systems under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

心臓弁修復の世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Cardiac Valve Repairs – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Cardiac Valve Repairs – Medical Devices Pipeline Assessment, 2016″ provides an overview of Cardiac Valve Repairs currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Valve Repairs pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Cardiac Valve Repairs under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Cardiac Valve Repairs and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Cardiac Valve Repairs under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

先進創傷治療の世界市場:医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Advanced Wound Management – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Advanced Wound Management – Medical Devices Pipeline Assessment, 2016″ provides an overview of Advanced Wound Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Advanced Wound Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Advanced Wound Management under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Advanced Wound Management and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Advanced Wound Management under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

ガス絶縁開閉装置(GIS)の世界市場2016:市場規模、競争環境、主要国分析、予測

2017年3月6日 // 0 Comments

Gas Insulated Switchgear Market, Update 2016 – Global Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020
Summary

GlobalData’s latest report “Gas Insulated Switchgear Market, Update 2016 – Global Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020” provides comprehensive information and understanding of the GIS market. The report offers in-depth analysis of GIS market at global, regional (Asia-Pacific, Americas, Europe, and Middle East and Africa) and key countries (the US, Canada, Germany, the UK, France, Saudi Arabia, China, India, Japan and Australia) level. The report analyzes the global and regional GIS market value and volume by voltage segment for the historic (2010-2015) and forecast (2016-2020) periods. The report also offers the country-level analysis of GIS market value and volume by voltage segment for the historic and forecast periods. The report covers the drivers and restraints affecting the GIS market and the competitive landscape for respective countries in 2015. The report is built using data and information sourced from primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report analyses GIS market. It includes –
– Analysis of the growth of GIS market with a focus on market value and volume in global and regional level including Asia-Pacific, Americas, Europe, and Middle East and Africa.
– The report provides GIS market analysis for key countries including the US, Canada, Germany, the UK, France, Saudi Arabia, China, India, Japan and Australia.
– The report offers country level GIS market value and volume for the historical (2010-2015) and forecast (2016-2020) periods.
– It provides competitive landscape at country level for the year 2015 and profiles of major players in GIS market.
– Qualitative analysis key market drivers and restraints and analysis of their impacts in GIS market is also discussed.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
– Facilitate decision-making by analyzing historical and forecast data on GIS market
– Develop strategies based on developments in the GIS market
– Identify key partners and business-development avenues, based on an understanding of the movements of the major competitors in the GIS market
– Respond to your competitors’ business structure, strategies and prospects

ワイヤーラインサービスの世界市場2016-2022

2017年2月10日 // 0 Comments

According to Stratistics MRC, the Global Wireline Services market is accounted for $17.35 billion in 2015 and is expected to reach $34.06 billion by 2022 growing at a CAGR of 10.1%. There is constant growth in the oil & gas exploration and production activities for finding new unconventional resources, which massively supports the wireline services market growth. These wireline services are essential for exploration, completion, drilling, intervention, and stimulation in oil and gas industries. The key factors driving wireline services market include growing exploration and production activities, global demand for oil & gas, technological advancements, increased oil production, and exploration activities for shale gas. However, increasing focus on renewable energy, stringent environmental rules and regulations, and decrease in crude oil prices are limiting the market growth.

In 2015, well completion segment held the largest share with more than 60% in total wireline services market. Electric line wireline type is the largest technology segment due to its usage in well logging services. The accomplished usage of wireline services together with the rising oil and gas production is the major driver for the market growth. North America has the largest market for wireline services and is expected to continue its growth during the forecast period due to rapidly increasing oil and gas production levels and logging services.

Some of the key players in global market include Archer Limited, Baker Hughes Incorporated, Basic Energy Services, Inc., C&J Energy Services Ltd., Casedhole Solutions, Expro International Group Holding Ltd., FMC Technologies, GE Oil & Gas, Halliburton Company, Nabors Industries Ltd., National Oilwell Varco, Inc., Oilserv, Pioneer Energy Services Corp., Schlumberger Limited, Superior Energy Services, Inc., Weatherford International PLC and Wireline Engineering Ltd.

Services Covered:
• Well Intervention
• Completion
• Logging

Technologies Covered:
• Electric Line
• Slick Line

Applications Covered:
• Offshore
• Onshore

Hole Types Covered:
• Open Hole
• Cased Hole

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

風力発電の世界市場2016-2022

2017年2月10日 // 0 Comments

According to Stratistics MRC, the Global Wind Power market is accounted for $185.47 billion in 2015 and is expected to reach $310.54 billion by 2022 growing at a CAGR of 7.6%. The wind power generation is estimated to drive the market over next decade due to increase in renewable energy. Nations across the globe are supporting the renewable energy including wind power, solar power, biomass, hydro power, to reduce the carbon emissions. Wind power’s growth is increasingly driven by its competitive pricing, because it enhances energy security and price stability.

Among the applications, commercial segment accounted for the largest market share owing to the rising awareness of people about green and clean energy. Moreover, Europe accounted for the largest market share on account of rising government regulations for the clean eco-friendly energy, whereas, Asia Pacific is expected to be the fastest growing region due to china, which has been the main driver for the growth in industry.

Some of the key players of the Wind Power market include Alstom Wind, S.L.U., Cs Wind Corp.,
Dong Energy A/S, Espe Srl, Green Wind Energy A/S, Gresa Group, Hyosung Corp., Inox Wind Ltd., Itw Windgroup, Kliux Energies, Mitsubishi Heavy Industries Ltd., Senwei Energy Technology Inc., Southwest Windpower Inc., Turbina Energy Ag and Vestas Wind Systems A/S.

Applications Covered:
• Industrial
• Residential
• Commercial
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

ウェアラブル電子機器の世界市場2016-2022

2017年2月10日 // 0 Comments

According to Stratistics MRC, the Global Wearable Electronics market is expected to reach $43.81 billion by 2022 growing at a CAGR of 21.3% from 2015 to 2022. Incursion of wireless connectivity, increasing demand for portable applications in networking, positioning, and communication, wearable’s with multiple sensors and adoption of electronic smart-textiles are some of the major factors driving the market growth. In addition, raising penetration of Internet of Things (IoT), increasing adoption of wearable electronics in health applications are the factors fueling the market growth. However, higher prices and power consumption issues are the factors limiting the market growth. The future growth lies in key enabling technologies, multi featured and multi application devices.

North America commanded the largest market for wearable electronics with US accounting for around 70%. Asia Pacific is expected to grow at a faster rate during the forecast period. The implications of wearable technology can influence the fields of healthcare, education, enterprise, finance, transportation, gaming and music. These technologies will tend to incorporate functional, portable electronics into individuals daily lives. The adoption of wearable electronics in mobile money, education, gaming, healthcare & fitness are expected to fuel the wearable electronics market.

Some of the key players in global wearable electronics market include Adidas Ag, Apple, Inc., AT & T Inc., Fitbit, Inc., Garmin Ltd., Google, Inc., Jawbone Inc., LG Electronics Inc., Nike, Inc., Pebble Technology Corp., Qualcomm, Inc., Samsung Electronics Co. Ltd., Sony Corp, Texas Instruments, Inc., and Xiaomi Technology Co. Ltd.

Products Covered:
• Wrist Wear
o Wrist Bands
o Wrist Wear Computers and Watches
• Neck Wear
o Ties and Collars
o Fashion and Jewellery
• Eye Wear
o Smart Glasses and Goggles
o Contact Lenses and Others
• Foot Wear
o Special Application Foot Wear
o Casual Foot Wear
• Body Wear
o Arm & Leg Wear
o Clothing and Inner Wear
o Fashion & Apparel
• Other Wearable Electronics
o Smart Headsets
o Ring Scanners
o Head Bands

Technologies Covered:
• Computing Technologies
• Display Technologies
o Augmented Reality
o Head Mounted Displays (HMD)
o Head-Up Display (HUD)
• Speech Recognition
• Sensor Technologies
o Mems
o Accelerometers
• Positioning Technologies
o GPS
o Digital Compass
• Networking Technologies
o ANT+
o Bluetooth
o Wi-Fi
o NFC

Components Covered:
• Sensing
• Display
• Interface
• Memory
• Control
• Positioning and Networking
• Power Supply
• PCBs
• Battery
• Audio
• Camera
• Other Components

Applications Covered:
• Consumer Electronics
o Multi-Function applications
o Fitness/Sports Applications
o Garments & Fashion Applications
o Infotainment & Multimedia Applications
o Others Consumer Electronics
• Healthcare
o Clinical
o Non-Clinical
• Enterprise & Industrial
o Logistics, Packaging, & Warehouse Applications
o Other Enterprise & Industrials
• Entertainment applications
• Defense
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

1 2 3 4 13